Injected nanoparticles: the combination of experimental systems to assess cardiovascular adverse effects.
Vlasova MA, Tarasova OS, Riikonen J, Raula J, Lobach AS, Borzykh AA, Smirin BV, Kauppinen EI, Eletskii AV, Herzig KH, Salonen J, Tavi P, Lehto VP, Järvinen K.
Vlasova MA, et al.
Eur J Pharm Biopharm. 2014 May;87(1):64-72. doi: 10.1016/j.ejpb.2014.02.001. Epub 2014 Feb 14.
Eur J Pharm Biopharm. 2014.
PMID: 24530427